You are here

  • Home
  • Archive
  • Volume 29, Issue Suppl 4
  • P194 Epivin: a phase II double-blind randomised control trial investigating the use of epigallocatechin-3-gallate (veregen®, catephen®) vs placebo in the treatment of usual-typed vulval intraepithelial neoplasia

Article metrics

Article menu
Download PDFPDF
Poster exhibition Day 2
P194 Epivin: a phase II double-blind randomised control trial investigating the use of epigallocatechin-3-gallate (veregen®, catephen®) vs placebo in the treatment of usual-typed vulval intraepithelial neoplasia

 

Online download statistics by month:

Online download statistics by month: November 2019 to April 2024

AbstractFullPdf
Nov 20196202
Dec 2019500
Jan 20202000
Feb 20202000
Mar 20204001
Apr 20202800
May 20201900
Jun 20202603
Jul 20205300
Aug 20203300
Sep 20206500
Oct 20206700
Nov 20204600
Dec 20208102
Jan 20214101
Feb 2021800
Mar 20212400
Apr 20211500
May 20211400
Jun 2021100
Aug 2021200
Sep 2021500
Oct 2021800
Nov 20213901
Dec 20212600
Jan 20222600
Feb 20223502
Mar 20222200
Apr 20222800
May 20223300
Jun 20223300
Jul 20225000
Aug 20223501
Sep 20221200
Oct 20221400
Nov 20223600
Dec 20222502
Jan 20231500
Feb 20233700
Mar 20232601
Apr 20232100
May 20232200
Jun 20231800
Jul 20232900
Aug 20234600
Sep 20232000
Oct 202310100
Nov 20234201
Dec 20233500
Jan 20241400
Feb 20244700
Mar 20245202
Apr 20244700
Total1669019